Highly elevated serum levels of CA 19-9 in choledocholithiasis: A case report

Cases Journal

Volumn 2, Issue 7, 2009, Pages

  Marcouizos, Georgios ^a   Ignatiadou, Eleftheria ^a   Papanikolaou, Georgios E ^a   Ziogas, Dimosthenis ^a   Fatouros, Michail ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; CA 19-9 ANTIGEN;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BACKACHE; BILE DUCT DILATATION; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHILL; CHOLECYSTECTOMY; CHOLEDOCHOTOMY; COMMON BILE DUCT STONE; EPIGASTRIC PAIN; FEMALE; FEVER; HUMAN; JAUNDICE;

EID: 77953391232     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.4076/1757-1626-2-6662     Document Type: Article

References (9)

1. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P: Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 1979, 5:957-971.
2. Barone D, Onetto M, Conio M, Paganuzzi M, Saccomanno S, Aste H, Pugliese V: CA 19-9 assay in patients with extrahepatic cholestatic jaundice. Int J Biol Markers 1988, 3:95-100.
3. Steinberg W: The clinical utility of the CA 19-9 tumorassociated antigen. Am J Gastroenterol 1990, 85:350-355.
4. Arends JW, Verstynen C, Bosman FT, Hilgers J, Steplewski Z: Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study. Hybridoma 1983, 2:219-229.
5. Craxi A, Patti C, Aragona E: Serum CA 19-9 levels in patients with hepatocellular carcinoma or cirrhosis. Ital J Gastroenterol 1985, 17:288-289.
6. Oguchi H, Homma T, Nagata A, Kawa S, Hirabayashi H, Tamura Y, Monno S, Shirai T, Shimakura K, Koike Y, Matsuda Y, Furuta S, Shiga T, Hayashi S, Miyazawa K: Monoclonal antibody-defined tumor marker CA 19-9: evaluation of its clinical usefulness, using the radioimmunometric assay for CA 19-9 (in Japanese). Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 1984, 81:1430-1435.
7. Sheen-Chen SM, Sun CK, Liu YW, Eng HL, Ko SF, Kuo CH: Extremely elevated CA 19-9 in acute cholangitis. Dig Dis Sci 2007, 52:3140-3142.
8. Murohisa T, Sugaya H, Tetsuka I, Suzuki T, Harada T: A case of common bile duct stone with cholangitis presenting an extraordinarily high serum CA 19-9 value. Intern Med 1992, 31:516-520.
9. Lim BC, Park ET, Yoo KS, Seo DW, Lee SK, Min YI: A new strategy for the application of CA 19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999, 94:1941-1946.